Abstract: The present invention relates to a bispecific antibody molecule, as well as a method for producing the same, its use and a nucleic acid molecule encoding the bispecific antibody molecule. The invention in particular provides an antibody molecule that is capable of mediating target cell restricted activation of immune cells.
Type:
Grant
Filed:
November 12, 2012
Date of Patent:
August 1, 2017
Assignee:
SYNIMMUNE GMBH
Inventors:
Gundram Jung, Michael Durben, Ludger Grosse-Hovest
Abstract: The present invention relates to a bispecific antibody molecule, as well as a method for producing the same, its use and a nucleic acid molecule encoding the bispecific antibody molecule. The invention in particular provides an antibody molecule that is capable of mediating target cell restricted activation of immune cells.
Type:
Application
Filed:
November 12, 2012
Publication date:
April 30, 2015
Applicant:
SYNIMMUNE GMBH
Inventors:
Gundram Jung, Michael Durben, Ludger Grosse-Hovest